Global Tech Company Eybna Empowers Next Generation of Wellness Products with Receptor-Specific ™ Formulations
The basic technology behind these formulations is the culmination of nearly a decade of scientific research and analysis of biological data. Each formulation is made up of specific active botanical compounds that work together to synergistically activate receptors in the body’s endocannabinoid, GABAergic and serotonergic systems. This has resulted in a line of functional consumer products based on terpenes, the first of its kind.
This first version includes 10 specific receiversâ¢ proprietary formulations of terpenes and cannabinoids, including:
- CB1â¢ Receptor specific formulation: This formulation is designed to activate the central CB1 receptor in the endocannabinoid system. The CB1 receptor is known to be activated by ??9-THC and associates with pain relief and sleep aid.
- CB2â¢ Receptor specific formulation: This formulation is designed to activate the CB2 receptor in the endocannabinoid system. The CB2 receptor is known to be activated by CBD and associated with anti-anxiety and anti-inflammatory properties.
- 5-HT3â¢ Receptor specific formulation: This formulation is designed to activate the 5-HT3 receptor in the serotonergic system. The 5-HT3 receptor is known to be activated by psilocybin and associated with cognitive functions such as concentration, learning and memory.
- TRPV1â¢ Receptor specific formulation: This formulation is designed to activate the TRPV1 receptor in the endocannabinoid system. The TRPV1 receptor is known to be activated by CBD and capsaicin. It is associated with perception of inflammation and pain.
Over the years of collecting data from different sources, including big data ethnobotanical research, in vitro and in vivo studies, and in silico Computer-assisted biological screening, Eybna has developed the largest phytochemical database in the world. This phytochemical database maps the chemical and biological activities of thousands of compounds and tracks their interaction with receptors in the human body.
The end results are unmatched, data-driven formulations allowing CPG and cannabis brands to design their own personalized wellness products and achieve desired effects in a variety of product carriers – from inhalables, consumables to topicals. and more.
âEybna is proud to meet the needs of hundreds of millions of people around the world to improve their quality of life by introducing a functional and pharmacologically active class of botanicals. Eybna’s pioneering technology utilizes a wide range of the most advanced research tools available. to science today, with the aim of making natural compounds safer and more effective than synthetic pharmaceutical drugs for certain wellness needs, âsaid CEO and co-founder of Eybna Nadav eyal.
âBy extracting the therapeutic benefits of natural compounds, such as terpenes and cannabinoids, Eybna provides pharmacologically active solutions in an easily applicable formulation form for indications such as sleep, pain and anxiety,â added Eyal. The new Receptor-Specific â¢ line of formulations is a milestone in Eybna’s continued efforts for predictable cannabis use, expanding our reach from recreational to functional, meeting the needs of many more people around the world. “
Global brands in the CPG, wellness and cannabis markets now have the ability to unlock new, targeted and specific experiences, all backed by science.
In addition to expanding its product offering in the United States, Eybna introduced NT-VRL earlier this yearÂ®, a new, patented, data-driven terpene formulation for which studies have shown potential to serve as the prevention and anti-inflammatory and antiviral treatment of human coronaviruses, as published in the peer-reviewed journal Life.
Eybna will present its full range of products, including the new Specific functional line receiverâ¢ formulas at MJBizCon in Las Vegas of October 20-22. The company will exhibit at MJBizCon North Hall, booth # N2521.
For more information on Eybna, its products, technology, science and white papers, please visit www.eybna.com or contact Avichai Elbaz To [emailÂ protected].
Eybna is a pioneering technology company and terpenes manufacturer with US offices in California and R&D centers in Israel and Colorado. With an avant-garde research and development team, made up of highly qualified doctors. scientists and engineers, Eybna researches the therapeutic benefits of phytochemicals in cannabis to advance the mission of improving human health. Eybna’s extensive proprietary database of phytochemicals in cannabis, along with partnerships with universities and leading industry professionals, allow the company to systematically integrate cutting-edge research into the process. development, transforming valuable scientific knowledge into easily applicable products that meet needs and improve consumer experiences. worldwide. Connect with us on www.eybna.com
Contact: Alex rush